Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.
2.

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.

Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.

J Am Soc Nephrol. 1998 Mar;9(3):444-50.

4.

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.

Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B, et al.

N Engl J Med. 1989 Jan 5;320(1):8-13.

PMID:
2642605
5.

A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.

Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, et al.

Kidney Int. 1995 Nov;48(5):1600-4.

6.

Treatment of membranous lupus nephritis.

Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C.

Am J Kidney Dis. 1998 Apr;31(4):681-6.

PMID:
9531186
7.

Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.

Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.

Ann Intern Med. 1994 Sep 1;121(5):328-33.

PMID:
8042821
8.

Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.

Polenakovik MH, Grcevska L.

Am J Kidney Dis. 1999 Nov;34(5):911-7.

PMID:
10561149
9.

Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.

Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T, et al.

N Engl J Med. 1984 Apr 12;310(15):946-50.

PMID:
6366560
10.

Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.

Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.

Kidney Blood Press Res. 2009;32(4):263-7. doi: 10.1159/000239539. Epub 2009 Sep 21.

11.

A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.

Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.

Am J Kidney Dis. 2006 Feb;47(2):233-40.

PMID:
16431252
12.

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.

Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A.

Cochrane Database Syst Rev. 2014 Oct 16;(10):CD004293. doi: 10.1002/14651858.CD004293.pub3. Review.

PMID:
25318831
13.
14.

The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.

Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.

Clin Nephrol. 2004 Jan;61(1):17-24.

PMID:
14964453
15.

Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.

Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F.

Proc Eur Dial Transplant Assoc. 1983;19:717-23.

PMID:
6348763
17.

Membranous nephropathy--still a treatment dilemma.

Cameron JS.

N Engl J Med. 1992 Aug 27;327(9):638-9. No abstract available.

PMID:
1640957
18.

Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.

du Buf-Vereijken PW, Branten AJ, Wetzels JF; Membranous Nephropathy Study Group.

Nephrol Dial Transplant. 2004 May;19(5):1142-8. Epub 2004 Feb 19.

PMID:
14993502
19.

Treatment of the nephrotic syndrome with cyclosporin A.

Ponticelli C.

J Autoimmun. 1992 Apr;5 Suppl A:315-24. Review.

PMID:
1503627
20.

Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.

Torres A, Domínguez-Gil B, Carreño A, Hernández E, Morales E, Segura J, González E, Praga M.

Kidney Int. 2002 Jan;61(1):219-27.

Supplemental Content

Support Center